Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Research
    • Treatments
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care
    Oncology nurse education
    Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care
    January 13, 2023
    Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results
    Pancreatic cancer
    Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results
    November 11, 2022
    The Life of Marie Curie and Her Contributions to Oncology
    Cancer treatments
    The Life of Marie Curie and Her Contributions to Oncology
    November 07, 2022
    Post-Flooding Natural Disaster Cancer Considerations and Patient Education Points
    Patient safety
    Post-Flooding Natural Disaster Cancer Considerations and Patient Education Points
    September 28, 2022
    Can Patients Use Continuous Glucose Monitors During Radiation Therapy for Cancer?
    Radiation therapy
    Can Patients Use Continuous Glucose Monitors During Radiation Therapy for Cancer?
    August 19, 2022
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
  • Topic

    Cancer screening

    Pancreatic Cancer Surveillance Programs Lead to Earlier Diagnoses and Better Outcomes
    Pancreatic cancer

    Pancreatic Cancer Surveillance Programs Lead to Earlier Diagnoses and Better Outcomes

    Most patients at high risk for developing pancreatic cancer whose disease was found while participating in a screening program were diagnosed with early-stage cancers, according to study findings published in the Journal of Clinical Oncology.

    January 25, 2023
    HRSA-Funded Health Centers and NCI-Designated Cancer Centers Partner to Improve Equity in Cancer Screening
    Cancer screening

    HRSA-Funded Health Centers and NCI-Designated Cancer Centers Partner to Improve Equity in Cancer Screening

    The U.S. Department of Health and Human Services, through the Health Resources and Services Administration, awarded more than $5 million in September 2022 to 11 HRSA-funded community health centers to help underserved populations access cancer screenings and early detection services in partnership with National Cancer Institute-designated cancer centers.

    November 30, 2022
    Testicular Cancer Survivors May Need Fewer Monitoring Scans
    Cancer screening

    Testicular Cancer Survivors May Need Fewer Monitoring Scans

    Monitoring early-stage testicular cancer survivors for disease recurrence after surgery using either magnetic resonance imaging or fewer computed tomography scans is just as effective as more frequent intervals, researchers reported in study findings published in the Journal of Clinical Oncology.

    September 21, 2022
    CDC Awards $215 Million to Advance President Biden’s Cancer Moonshot
    Cancer screening

    CDC Awards $215 Million to Advance President Biden’s Cancer Moonshot

    To support the objectives of President Joe Biden’s relaunched Cancer Moonshot initiative, the Centers for Disease Control and Prevention awarded $215 million to three national cancer programs in June 2022. The funds are part of a $1.1 billion investment in cancer prevention and control.

    September 07, 2022
    As Skin Cancer Screening Increases, Clinicians Find More Thin Melanomas
    Cancer screening

    As Skin Cancer Screening Increases, Clinicians Find More Thin Melanomas

    Although regular population-based skin cancer screening isn’t recommended by the U.S. Preventive Services Task Force, more Americans are getting full-body skin exams at dermatology visits or other provider services. Data from a new study published in JAMA Dermatology suggest that the screening uptick is associated with increased diagnoses of early-stage, in situ melanoma, leading the researchers to raise concerns about overdiagnosis.

    August 17, 2022
    Funding to Advance Equity in Cancer Screening and Follow-Up Care Allocated by the HHS
    Cancer screening

    Community Health Centers Get Funding to Advance Equity in Cancer Screening and Follow-Up Care

    With the relaunch of the Biden-Harris administration’s Cancer Moonshot initiative, the fight against cancer is back in the government spotlight. To support the Moonshot’s goals, in May 2022 the U.S. Department of Health and Human Services (HHS) allocated $5 million to the Health Resources and Services Administration-funded community health centers.

    June 30, 2022
    Use of Anxiety and Depression Drugs Linked to Increased PSA Testing
    Cancer research

    Use of Anxiety and Depression Drugs Linked to Increased PSA Testing

    Patients who take anxiety or depression medication are more likely to obtain prostate-specific antigen tests, according to study findings that researchers presented at the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium.

    June 22, 2022
    More Patients Are Skipping Their Cervical Cancer Screenings
    Research

    More Patients Are Skipping Their Cervical Cancer Screenings

    Nearly a quarter of patients who are eligible for cervical cancer screening are overdue for their current tests, researchers said in study findings published in JAMA Network Open. The number grew nearly 10% since 2005—representing a steady increase in missed screening over time—and was higher in different sociodemographic groups because of factors related to social determinants of health.

    May 04, 2022
    CDC Emphasizes Importance of Cancer Screenings During COVID-19
    Cancer screening

    CDC Emphasizes Importance of Cancer Screenings During COVID-19

    “Cancer doesn’t wait, and neither should you,” the Centers for Disease Control and Prevention (CDC) urged patients in its new cancer screening adherence campaign. The COVID-19 pandemic has created barriers to regular health visits, screenings, and treatment for individuals everywhere, and providers and organizations alike are seeking solutions.

    April 18, 2022
    APRN Roles Evolve to Address Cancer Screening, Treatment Adherence, and Public Health
    Advanced Practice Nursing (APRN)

    APRN Roles Evolve to Address Cancer Screening, Treatment Adherence, and Public Health

    Responses to pandemic-related screening and treatment delays have created new opportunities for oncology advanced practice RNs (APRNs), too. In both their institutions and communities, APRNs are guiding patients and providers to reverse the increases in late cancer diagnoses, morbidity, and mortality—ultimately improving outcomes.

    April 14, 2022
    CMS Expands Eligibility Criteria for Lung Cancer Screening With Low-Dose Computed Tomography
    Lung Cancer

    CMS Expands Eligibility Criteria for Lung Cancer Screening With Low-Dose Computed Tomography

    More Medicare beneficiaries now meet age, smoking history, and other criteria for lung cancer screening and are now eligible to receive low-dose computed tomography (LDCT), according to a February 2022 memo from the Centers for Medicare and Medicaid Services (CMS).

    April 06, 2022
    How to Promote and Maintain Cancer Screening as COVID-19 Persists
    Cancer screening

    How to Promote and Maintain Cancer Screening as COVID-19 Persists

    For the past two years, patients and providers have turned their attention to combatting a global health threat. We’ve nearly crumbled amid the chaos, but carried on through acts of comfort and innovation. However, as we pled for an end to this nightmare, for heard immunity through vaccination, another health threat took a backseat. Cancer screening rates plummeted, particularly among communities of color. Oncology nurses can use evidence-based interventions to increase screening rates for all patients with cancer.  

    March 18, 2022
    Preventive Healthcare Guidelines for Women and Children Improve Under Affordable Care Act
    Clinical practice guidelines

    Preventive Healthcare Guidelines for Women and Children Improve Under Affordable Care Act

    Comprehensive preventive care and screening guidelines for women and infants, children, and adolescents under the Affordable Care Act expanded in January 2022, requiring certain group health plans and insurance plans to provide coverage with no out-of-pocket costs for preventive health services, according to the U.S. Department of Health and Human Services (HHS) and U.S. Health Resources and Services Administration (HRSA).

    March 11, 2022
    Rural Populations’ Fatalistic Perceptions About Cancer May Contribute to Cancer Disparities
    Cancer research

    Rural Populations’ Fatalistic Perceptions About Cancer May Contribute to Cancer Disparities

    Compared to people living in urban areas, on a nationwide U.S. survey, rural populations were more likely to report believing that cancer is unpreventable and always fatal. Researchers reported the survey findings and analysis in Cancer Epidemiology, Biomarkers, and Prevention.

    March 09, 2022
    CDC Releases Video Series About Gynecologic Cancers as Part of Gynecologic Cancer Campaign
    Patient resources

    CDC Releases Video Series About Gynecologic Cancers

    Multimedia tools and resources can help patients learn more about a cancer diagnosis, treatment regimens, procedures, and follow-up care, among other important topics, and many institutions and organizations have jumped onto the bandwagon to create those resources for their patients. A new video series on gynecologic cancers from the Centers for Disease Control and Prevention (CDC) adds another patient education resource to oncology nurses’ toolbox.

    October 28, 2021
    What Is a Liquid Biopsy?
    Clinical practice

    What Is a Liquid Biopsy?

    All cells (healthy cells and tumor cells) in the body shed DNA, called cell-free DNA (cfDNA). When it’s only from tumor cells, it’s referred to as circulating tumor DNA (ctDNA), although cfDNA and ctDNA are sometimes used interchangeably.

    October 25, 2021
    New Study Supports CRC Screening for People Older Than 75
    Cancer screening

    New Study Supports CRC Screening for People Older Than 75

    Colorectal cancer (CRC) screening may be beneficial for certain patients aged 75–85, according to findings from a new study. The researchers reported the results in JAMA Oncology.

    October 20, 2021
    FDA Launches National Black Family Cancer Awareness Week
    Cancer health disparities

    FDA Launches National Black Family Cancer Awareness Week

    African Americans have a higher cancer burden and face greater obstacles to cancer prevention, detection, treatment, and survival, according to the American Cancer Society. Health organizations such as ONS and the U.S. Food and Drug Administration (FDA) are dedicated to breaking down barriers and improve access to quality care and resources for those patients. To increase cancer awareness in one of the most vulnerable segments of the U.S. population, the FDA’s Oncology Center of Excellence (OCE) dedicated June 17–23, 2021, as National Black Family Cancer Awareness Week.

    July 07, 2021
    USPSTF Recommends Colorectal Cancer Screening Should Begin at 45
    Cancer screening

    USPSTF Recommends Colorectal Cancer Screening Should Begin at 45

    According to the U.S. Preventive Services Task Force (USPSTF), colorectal cancer is the third leading cause of cancer death for both men and women, with an estimated 52,980 individuals in the U.S. projected to die from the disease in 2021. After evaluating the current evidence and conducting a modeling study, USPSTF updated its recommendations on colorectal cancer screening.

    July 05, 2021
    Survey Results Support Predicted Effects of Pandemic Screening Drop
    Cancer screening

    Survey Results Support Predicted Effects of Pandemic Screening Drop

    Clinicians are already seeing an increase in late-stage cancer diagnoses that they attribute to the pandemic-driven pause in cancer screening and treatment adherence, according to the results of a survey from the American Society for Radiation Oncology.

    May 26, 2021
    Text Messaging Reduces Disparities in Colorectal Cancer Screening
    Research

    Text Messaging Reduces Disparities in Colorectal Cancer Screening

    A series of text reminders to complete an at-home fecal immunochemical test increased screening completion rates by nearly 20%, researchers reported in study findings published in the Journal of General Internal Medicine. The results are particularly encouraging because almost 90% of the participants were Black, a population that typically has low screening adherence rates but higher incidence of and mortality from colorectal cancer.

    May 19, 2021
    Cancer Deaths Decline, CDC Says, but More Prevention and Screening Are Needed
    Cancer screening

    Cancer Deaths Decline, CDC Says, but More Prevention and Screening Are Needed

    Cancer mortality rates decreased by 27% from 1999–2019, the Centers for Disease Control and Prevention (CDC) reported in February 2021. However, cancer remains the one of the leading causes of death in the United States, second only to heart disease, and disparities remain. More needs to be done to decrease risk and increase prevention.

    May 13, 2021
    The Case of the Transgender Considerations for Cancer Screening
    Patient Support

    The Case of the Transgender Considerations for Cancer Screening

    Sally, a nurse practitioner in a cancer survivorship clinic, is preparing to discuss screening and surveillance guidelines with Jonah, a 32-year-old survivor of Hodgkin lymphoma. Sally reviews Jonah’s patient history form and notes that Jonah uses he and him pronouns. His gender identity is male and sex assigned at birth was female. Jonah’s surgical history includes gender-affirming surgery on chest tissue (also known as top surgery), and his current medications include supplemental testosterone. Jonah also specifies that he is transmasculine—an umbrella term used to indicate that Jonah feels a connection with masculinity.

    April 20, 2021
    Research Validates Tools to Increase Screening in Communities of Color
    Cancer research

    Research Validates Tools to Increase Screening in Communities of Color

    Reduced adherence to recommended screening and prevention relates to a lack of knowledge and barriers like inadequate insurance, low engagement with primary care, time constraints, and misconceptions about risks of screening or their individual risk of developing cancer. We must do a better job of educating people about cancer screening and linking them to affordable or free services. 

    March 24, 2021
    All Patients, Regardless of Insurance, Must Have Access to Cancer Screening
    Cancer screening

    All Patients, Regardless of Insurance, Must Have Access to Cancer Screening

    To increase access to breast and cervical cancer screening, U.S. Congress passed the Breast and Cervical Cancer Mortality Prevention Act of 1990, which led to the creation of the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Because of NBCCEDP, eligible women who are low-income, underserved, and underinsured receive free breast and cervical cancer screening and diagnostic testing. 

    March 23, 2021
    Lung Cancer Screening Guidelines to Reduce Disparities May Increase Them Instead—But Risk Model Can Help
    Cancer screening

    Lung Cancer Screening Guidelines to Reduce Disparities May Increase Them Instead—But Risk Model Can Help

    The draft 2020 U.S. Preventive Services Task Force (USPSTF) lung cancer screening recommendations were intended to increase the number of high-risk minorities eligible for lifesaving tests. And they do, but not as much as USPSTF anticipated, still leaving gaps and disparities, researchers reported in the Journal of the National Cancer Institute. They created a risk model to augment the guidelines that eliminated the disparities for most racial groups.

    March 10, 2021
    CDC Campaign Fights Declining Cancer Screening Rates
    Cancer screening

    CDC Campaign Fights Declining Cancer Screening Rates

    Nearly 1.9 million people in the United States will be diagnosed with cancer in 2021. However, overall cancer screenings dropped roughly 80% in 2020 because of the COVID-19 coronavirus pandemic and statewide stay-at-home orders. To combat the decline, the Centers for Disease Control and Prevention’s (CDC’s) new outreach campaign reminds patients and providers of the importance of cancer screening. 

    March 05, 2021
    Patient Education Reduces Barriers and Increases Adherence Rates
    Patient Education

    Patient Education Reduces Barriers and Increases Adherence Rates

    Patient education is an essential aspect of cancer prevention. Nearly 1.9 million people in the United States will be diagnosed with cancer in 2021, and modifiable risk factors are responsible for approximately 35% of cancer-related deaths. However, less than half of Americans understand the major risk factors that contribute to the development of cancer.

    March 02, 2021
    Medicaid Expansion Coincides With Earlier Colon Cancer Diagnosis Rates
    Research

    Medicaid Expansion Coincides With Earlier Colon Cancer Diagnosis Rates

    U.S. states that adopted the Affordable Care Act’s Medicaid expansion in January 2014 have earlier colon cancer diagnoses, enhanced access to care, and improved colon cancer surgical care than states that didn’t implement the expansion, researchers reported in Journal of the American College of Surgeons. Additionally, patients in the expansion states were more likely to have minimally invasive procedures and fewer urgent surgeries.

    February 24, 2021
    Older Adults Are Being Overscreened for Cancer
    Cancer screening

    Older Adults Are Being Overscreened for Cancer

    Many older adults are continuing cancer screenings beyond the recommended upper age limits, which range from age 65–75 years depending on the type of cancer screening, researchers reported in JAMA Network Open.

    November 25, 2020
    Non-Small Cell Lung Cancer Prevention, Screening, Diagnosis, Treatment, Side Effects, and Survivorship
    Lung Cancer

    Non-Small Cell Lung Cancer Prevention, Screening, Diagnosis, Treatment, Side Effects, and Survivorship

    Lung cancer is the leading cause of cancer death in the United States, accounting for about one quarter of cancer deaths, and more than a quarter of million lung cancer diagnoses are projected in the United States for 2020. Lung cancer has various types, pathologies, and histologies, each with its own prognosis and treatment plan. Non-small cell lung cancer consists of about 80%–85% of lung cancer diagnoses.

    November 05, 2020
    ACS Cervical Cancer Screening Guidelines Prefer HPV Over Pap Tests
    Cervical cancer

    ACS Cervical Cancer Screening Guidelines Prefer HPV Over Pap Tests

    People with a cervix who are aged 25–65 years should receive a human papillomavirus (HPV) test every five years, according to the new American Cancer Society (ACS) guidelines for cervical cancer screening.

    November 04, 2020
    A Primer on Urothelial Cancer
    Clinical practice

    A Primer on Urothelial Cancer

    The urinary system, including the bladder, ureters, urethra, and renal pelvis, is lined with urothelial tissue. Urothelial carcinoma is the predominant histologic type of cancer in that system, and 90% of tumors are located in the bladder. With more than 81,400 new cases and nearly 18,000 deaths estimated for 2020, bladder cancer is the fifth most prevalent type of cancer in the United States.

    September 21, 2020
    As True Detectives, Genetics Professionals Uncover the Meaning of True or Noninformative Negative Results
    Genetics & genomics

    As True Detectives, Genetics Professionals Uncover the Meaning of True or Noninformative Negative Results

    Patients who watch crime shows think that DNA testing is as simple as taking a cheek swab and getting the results in two minutes so the case is solved at the end of the 42-minute episode. The reality? DNA can be identified from buccal cells in a cheek swab, but results take several weeks to obtain and are not always a simple negative or positive.

    August 18, 2020
    A Single Blood Test Could One Day Identify 10 Types of Cancer
    Cancer research

    A Single Blood Test Could One Day Identify 10 Types of Cancer

    When combined with positron-emission and computed tomography, a multicancer blood test identified 10 different tumor types in a sample of women with no history of cancer, researchers reported in Science.

    August 05, 2020
    Develop Your Individual Cancer Screening Plan
    Cancer screening

    Develop Your Individual Cancer Screening Plan

    As oncology nurses, we know that catching cancer early through screening leads to better outcomes and increased survival rates. We ask our survivors and loved ones to prioritize their cancer screenings, reminding them, “I do not want to see you in my clinic chair or hospital bed with cancer, especially not at an advanced level.” Take care of yourself by giving yourself the same lecture.

    June 29, 2020
    Oral and Oropharyngeal Cancer Prevention, Screening, Treatment, and Survivorship Recommendations
    Cancer screening

    Oral and Oropharyngeal Cancer Prevention, Screening, Treatment, and Survivorship Recommendations

    Approximately 53,000 cases of oral and oropharyngeal cancer are diagnosed in the United States each year. Men are twice as likely to develop the disease, and it typically affects people older than 55.  

    April 21, 2020
    Adding MRI to Prostate Cancer Testing Improves Accuracy, NIH Study Says
    Prostate cancer

    Adding MRI to Prostate Cancer Testing Improves Accuracy, NIH Study Says

    Combining a traditional 12-point biopsy with magnetic resonance imaging (MRI) improves the accuracy of prostate cancer diagnosis, according to findings from a new National Institutes of Health (NIH) study published in the New England Journal of Medicine. 

    March 26, 2020
    Colorectal Cancer Prevention, Screening, Treatment, and Survivorship Recommendations
    Cancer screening

    Colorectal Cancer Prevention, Screening, Treatment, and Survivorship Recommendations

    Colorectal cancer (CRC) is the third most common cancer affecting men and women in the United States. When CRC is found at an early stage before it has spread, the five-year relative survival rate is about 90%, yet it remains a leading cause of cancer-related death among both genders. 

    March 17, 2020
    World Gets Closer to Identifying Cancer’s Genomic Drivers
    Genetics & genomics

    World Gets Closer to Identifying Cancer’s Genomic Drivers

    Although most cancers contain four to five driver mutations, those drivers remain unknown for about 5% of cancers, according to results of a series of studies examining genomes from 38 different cancer types. The international Pan-Cancer Analysis of Whole Genomes Consortium reported the findings in a collection of 23 articles published in Nature and other affiliated journals.

    February 25, 2020
    Women With Diabetes Are Less Likely to Get Cancer Screenings
    Research

    Women With Diabetes Are Less Likely to Get Cancer Screenings

    Modest differences may exist among women with diabetes compared to healthy controls when it comes to adhering to screening recommendations for breast, cervical, and colorectal cancers, according to results of a study published in Diabetologia.

    February 12, 2020
    Nurses Are Central to Lung Cancer Screening Conversations
    Cancer screening

    Nurses Are Central to Lung Cancer Screening Conversations

    Participation in clinician and patient conversations about lung cancer screening—as well as the actual screening itself—is relatively low. According to one study, only 3.9% of screening-
    eligible patients had undergone lung cancer screening. Because the screening recommendations are newer, most patients are unaware that they exist, and research highlights that only 10%–12% of the patient population has had conversations with their clinicians about it.

    February 10, 2020
    Ovarian Cancer: Prevention, Screening, Treatment, and Survivorship Recommendations
    Ovarian cancer

    Ovarian Cancer: Prevention, Screening, Treatment, and Survivorship Recommendations

    Even though its incidence is less common, ovarian cancer is the fifth leading cause of death from cancer in women, according to the American Cancer Society. It also estimated more than 22,000 new cases of ovarian cancer in 2019, with a five-year survival of 47% for all stages.

    February 06, 2020
    Blood Test May Show Earliest Warning of Breast Cancer
    Research

    Blood Test May Show Earliest Warning of Breast Cancer

    Identifying a panel of tumor-associated antigens and autoantibodies through a simple blood test may one day help providers diagnose the earliest stages of breast cancer, before clinical signs appear.

    February 05, 2020
    Updated NCCN Cancer Screening Guidelines Inform Practice and Prevention
    Clinical practice guidelines

    Updated NCCN Cancer Screening Guidelines Inform Practice and Prevention

    As an industry standard, the National Comprehensive Cancer Network (NCCN) screening guidelines have served a huge role in cancer prevention and early detection efforts, helping providers identify diagnoses early and give patients their best possible chance at survival. Ensuring screening guidelines are up to date and using the best available evidence is an ongoing process that requires an interprofessional approach.

    February 04, 2020
    The Value of Vigilance: New Screening Recommendations Are Vital for Cancer Prevention
    Cancer screening

    The Value of Vigilance

    Although society still hopes for that one big discovery to cure cancer, clinicians know that there’s already a tried and true method to give patients their best shot at survival: catching a diagnosis early or preventing one altogether.

    February 04, 2020
    Prostate Cancer Prevention, Screening, Treatment, and Survivorship Recommendations
    Prostate cancer

    Prostate Cancer Prevention, Screening, Treatment, and Survivorship Recommendations

    One in nine men will be diagnosed with prostate cancer, the second leading cause of death in men in the United States. Survival varies greatly depending on the disease’s severity and extent at diagnosis: five-year survival rates are near 100% for local or regional disease, but they drop to 30% for metastatic prostate cancer.

    January 27, 2020
    CDC Promotes Lung Cancer Screening Awareness and Prevention
    Lung Cancer

    CDC Promotes Lung Cancer Screening Awareness and Prevention

    As the leading cause of cancer death in the United States, lung cancer is pervasive and deadly. But like many cancers, patients have a better chance at successful treatment outcomes and survival if caught early through screening and early detection efforts. Despite lung cancer being the second most diagnosed cancer for men and women, not all Americans are aware of its screening recommendations. To address the gap in awareness, the Centers for Disease Control and Prevention (CDC) is promoting a new public health campaign on the issue.

    November 21, 2019
    Biomarker-Based Screening Test May Find Lung Cancer at Earlier Stages
    Lung Cancer

    Biomarker-Based Screening Test May Find Lung Cancer at Earlier Stages

    A blood test evaluating several biomarkers was able to reduce the number of lung cancers detected at later stages, according to study results presented at the 2019 World Conference on Lung Cancer.

    November 13, 2019
    Medicare Cancer Screening; ACA Remains Strong; Medicare for All Cost
    Affordable Care Act (ACA)

    Advanced Cancer Screening Coverage; ACA Remains Strong; Medicare for All Cost

    Precision medicine has a been a hot topic in health care for years now, but costs and coverage issues have created challenges to get patients the genetic testing they need at an affordable cost. In a memo from October 29, 2019, the Centers for Medicare and Medicaid Services (CMS) proposed extending Medicare coverage to pay for genetic sequencing tests for certain hereditary types of ovarian and breast cancer.

    November 04, 2019
    • Current page 1
    • Page 2
    • Next page
    • Last page Last »
    Trending Topics
    • Research
    • Treatments
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    • Clinical practice
    • U.S. Food and Drug Administration (FDA)
    • Health Policy
    • Immunotherapy
    View All Topics
     
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
  • © Copyright 2023 Oncology Nursing Society
     
    Back to Top ▲